MAP Pharmaceuticals, Inc. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 5, 2010

Attached files

file filename
10-K - FORM 10-K - MAP Pharmaceuticals, Inc.d10k.htm
EX-32.1 - CERTIFICATION OF PEO AND PFO REQUIRED UNDER RULE 13A-14(B) - MAP Pharmaceuticals, Inc.dex321.htm
EX-31.1 - CERTIFICATION OF PEO REQUIRED UNDER RULES 13A-14(A) OR 15D-14(A) - MAP Pharmaceuticals, Inc.dex311.htm
EX-31.2 - CERTIFICATION OF PFO REQUIRED UNDER RULES 13A-14(A) OR 15D-14(A) - MAP Pharmaceuticals, Inc.dex312.htm
EX-10.39 - FORM OF RSU GRANT AGREEMENT - MAP Pharmaceuticals, Inc.dex1039.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-157339 and No. 333-164894) and S-8 (No. 333-158253 and No. 333-146656) of MAP Pharmaceuticals, Inc. of our report dated March 4, 2010 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

San Jose, California

March 5, 2010

MAP Pharmaceuticals, Inc. Reports